<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941110-1-00076</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4702 -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG 0012 frnewline --> The next meeting of the Parties is scheduled for October  <!-- PJG 0012 frnewline --> 1994. At that session the Parties will review the  <!-- PJG 0012 frnewline --> recommendations by the Technology and Economic Assessment Panel  <!-- PJG 0012 frnewline --> and make final decisions on this round of essential use  <!-- PJG 0012 frnewline --> nominations.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> In 1993, the Parties to the Protocol modified the timetable  <!-- PJG 0012 frnewline --> for submission of essential use nominations to combine both  <!-- PJG 0012 frnewline --> halons and all the other class I controlled substances (except  <!-- PJG 0012 frnewline --> methyl bromide) and to reduce the overall length of time between  <!-- PJG 0012 frnewline --> nomination and decision. According to Decision V/18, essential  <!-- PJG 0012 frnewline --> use nominations for halon consumption and production for 1995 and  <!-- PJG 0012 frnewline --> beyond, and essential use nominations for all the other class I  <!-- PJG 0012 frnewline --> controlled substances (except methyl bromide) for 1997 and  <!-- PJG 0012 frnewline --> beyond, must be submitted to the Secretariat prior to January 1st  <!-- PJG 0012 frnewline --> of the year prior to the year for which production and  <!-- PJG 0012 frnewline --> consumption is being sought. <FOOTCITE>8</FOOTCITE>  Parties must submit essential use  <!-- PJG 0012 frnewline --> nominations for CFCs for 1997 (nominations for 1996 have already  <!-- PJG 0012 frnewline --> been considered) to the Montreal Protocol Secretariat by January  <!-- PJG 0012 frnewline --> 1, 1996. EPA will revise its domestic schedule to require that  <!-- PJG 0012 frnewline --> nominations be submitted at least three months prior to the  <!-- PJG 0012 frnewline --> Protocol Secretariat deadline for submission, and will issue a  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  notice in August 1994, calling for essential use  <!-- PJG 0012 frnewline --> nominations for halons for 1996 and beyond. The next call by EPA  <!-- PJG 0012 frnewline --> for other class I controlled substances will be in August of 1995  <!-- PJG 0012 frnewline --> for 1997 essential-use exemption nominations.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <FOOTNOTE> <FOOTNAME> <!-- PJG ITAG l=28 g=1 f=1 --> 8 <!-- PJG /ITAG -->  </FOOTNAME> <!-- PJG ITAG l=28 g=1 f=1 --> Decision V/18 also directed the Technology and Economic Assessment Panel to develop a ``Handbook of Essential Use Nominations.'' The Handbook is being prepared and will contain forms and instructions for how to apply for an essential-use exemption. When available, the Handbook may be obtained from the Stratospheric Protection Division, U.S. Environmental Protection Agency or the Ozone Secretariat of the Montreal Protocol in Nairobi. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </FOOTNOTE>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG 0012 frnewline --> b.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Domestic Implementation of Essential-Use Program.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Any essential use exemptions would also have to comply with  <!-- PJG 0012 frnewline --> the provisions of the CAA. Section 604 of the CAA authorizes the  <!-- PJG 0012 frnewline --> granting of specific exemptions from the phaseout schedules  <!-- PJG 0012 frnewline --> contained in the Clean Air Act for essential uses for methyl  <!-- PJG 0012 frnewline --> chloroform for which no safe and effective substitute is  <!-- PJG 0012 frnewline --> available (section 604(d)(1)), for limited quantities of class I  <!-- PJG 0012 frnewline --> substances solely for use in medical devices if such  <!-- PJG 0012 frnewline --> authorization is determined to be necessary (section 604(d)(2))  <!-- PJG 0012 frnewline --> and for limited quantities of halon&hyph;1211, halon&hyph;1301 and halon&hyph;2402 solely for use in aviation safety if no safe and effective  <!-- PJG 0012 frnewline --> substitute is available and if such authorization is necessary.  <!-- PJG 0012 frnewline --> The CAA also authorizes specific exemptions from the phaseout  <!-- PJG 0012 frnewline --> schedule of CFC&hyph;114, halon&hyph;1211, halon&hyph;1301 and halon&hyph;2402 for  <!-- PJG 0012 frnewline --> national security (section 604(f)).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> In today's action, EPA does not propose essential uses  <!-- PJG 0012 frnewline --> under the provisions of the CAA. However, EPA does propose to  <!-- PJG 0012 frnewline --> permit continued production for the essential uses authorized  <!-- PJG 0012 frnewline --> under the Protocol, so long as these essential use exemptions do  <!-- PJG 0012 frnewline --> not exceed amounts allowed in the schedule contained in section  <!-- PJG 0012 frnewline --> 604(a) of the CAA.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> As indicated on the table below, EPA is proposing essential  <!-- PJG 0012 frnewline --> uses for specified controlled substances for the years 1996 and  <!-- PJG 0012 frnewline --> 1997. As discussed in section A.1.c., ``The Post-Phaseout  <!-- PJG 0012 frnewline --> Procedures for Granting Destruction and Transformation Credits,''  <!-- PJG 0012 frnewline --> EPA proposes to authorize continued production for essential uses  <!-- PJG 0012 frnewline --> permitted under the Montreal Protocol, but not to exceed the  <!-- PJG 0012 frnewline --> maximum allowable limits set forth in section 604(a) of the CAA.  <!-- PJG 0012 frnewline --> As used in a previous example in section A.1.c., the CAA requires  <!-- PJG 0012 frnewline --> that in 1996, the maximum allowable production of CFC&hyph;12 may be  <!-- PJG 0012 frnewline --> no more than 40 percent of the quantity produced in the baseline  <!-- PJG 0012 frnewline --> year. Thus, in 1996, if total production of CFC&hyph;12 were to be  <!-- PJG 0012 frnewline --> used for essential uses, the amount produced for those essential  <!-- PJG 0012 frnewline --> uses may not exceed 40 percent of the quantity produced in the  <!-- PJG 0012 frnewline --> baseline year. Although production may be used for some  <!-- PJG 0012 frnewline --> combination of essential uses, destruction credits, or  <!-- PJG 0012 frnewline --> transformation credits, the total amount produced could not  <!-- PJG 0012 frnewline --> exceed the maximum allowable limits set forth in the CAA as  <!-- PJG 0012 frnewline --> reproduced in Table I below.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> To incorporate the essential-use provisions under the  <!-- PJG 0012 frnewline --> Montreal Protocol into our domestic allowance program, EPA is  <!-- PJG 0012 frnewline --> proposing the creation of a new class of allowances to be  <!-- PJG 0012 frnewline --> referred to as ``essential-use allowances.''  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> The essential-use allowances will be allocated to United  <!-- PJG 0012 frnewline --> States entities based on the nominations made to the Protocol  <!-- PJG 0012 frnewline --> which will be decided upon by the Parties at the October 1994  <!-- PJG 0012 frnewline --> meeting and at meetings thereafter. In the nominations to the  <!-- PJG 0012 frnewline --> Protocol, U.S. entities apply for an essential-use exemption from  <!-- PJG 0012 frnewline --> the production and consumption phaseout for a specific quantity  <!-- PJG 0012 frnewline --> of controlled substance for a specific use. EPA proposes using  <!-- PJG 0012 frnewline --> the applications that are agreed to by the Parties to the  <!-- PJG 0012 frnewline --> Protocol to make specific allocations of essential-use  <!-- PJG 0012 frnewline --> allowances. Although the TEAP has received applications for  <!-- PJG 0012 frnewline --> essential-use exemptions beyond 1997, today's proposal only  <!-- PJG 0012 frnewline --> includes those recommendations by the Panel for 1996 and 1997.  <!-- PJG 0012 frnewline --> In today's rulemaking, EPA proposes an allocation of essential-use allowances up to the amount being recommended by the  <!-- PJG 0012 frnewline --> Technology and Economic Assessment Panel to the Parties for their  <!-- PJG 0012 frnewline --> meeting in October 1994. It should be noted that the final  <!-- PJG 0012 frnewline --> essential-use allowances promulgated by EPA may not exceed the  <!-- PJG 0012 frnewline --> exemptions adopted by the Parties. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            